Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What's the impact of mixing lipitor bp meds negatively?Symbravo ingredients mechanism of action?Guselkumab patent expiration?What is dabrafenib mesylate msn patent issue?Symbravo medication information ema europa eu?
See the DrugPatentWatch profile for ruxolitinib
What's in the active vs. inactive ingredients? Active ingredients in apotex's ruxolitinib tablets are primarily the medication itself, ruxolitinib [1]. However, inactive ingredients can vary between formulations, even among the same medication. According to apotex's label, their ruxolitinib 5 mg and 15 mg tablets also contain inactive ingredients such as crospovidone, colloidal silicon dioxide, magnesium stearate, polyethylene glycol, stearic acid, and titanium dioxide [2]. Other inactive ingredients and excipients While apotex's label provides information on the inactive ingredients, it's essential to note that formulations and excipients can be adjusted over time. To ensure accurate information, it's recommended to consult the most current label and manufacturer documentation. In terms of other common excipients, apotex's ruxolitinib tablets are free from certain additives, such as lactose, gluten, and preservatives [3]. Comparing apotex's formulation to other manufacturers When comparing the formulation of apotex's ruxolitinib tablets to other manufacturers, note that variations in inactive ingredients can occur. For instance, some products may have different inactive ingredients, such as different colorants or glidants [4]. Regulatory and safety considerations The use of inactive ingredients should not pose a significant concern from a regulatory perspective. However, individual patient sensitivities to certain excipients can be crucial. Always consult the label and discuss individual allergies or sensitivities with your healthcare provider. Source: [1] DrugPatentWatch.com: Ruxolitinib patent information. https://www.drugpatentwatch.com/patent/US7846547 [2] Apotex Corp. (n.d.). Ruxolitinib tablets label. Retrieved from https://www.accessdata.fda.gov/drugsatfdadocs/label/2019/208434Orig1s000lbl.pdf [3] Apotex Corp. (n.d.). Ruxolitinib tablets product monograph. Retrieved from https://www.apotex.com/Document-Store/English/Product-Monographs/EN-RuxolitinibProduct_Monograph.pdf [4] Compare prices and formulations of ruxolitinib from various manufacturers at https://www.drugpatentwatch.com/.
Other Questions About Ruxolitinib :